CSIMarket Company Name, Ticker, Competitors, else..
 
Kuvatris Therapeutics Inc   (PXMD)
 
Price: $0.0007 $0.00 0.000%
Day's High: $0.000699999975040555 Week Perf: 40 %
Day's Low: $ 0.00 30 Day Perf: 40 %
Volume (M): 0 52 Wk High: $ 0.00
Volume (M$): $ 0 52 Wk Avg: $0.00
Open: $0.00 52 Wk Low: $0.00



 Market Capitalization (Millions $) 0
 Shares Outstanding (Millions) 9
 Employees 10
 Revenues (TTM) (Millions $) -
 Net Income (TTM) (Millions $) -14
 Cash Flow (TTM) (Millions $) -1
 Capital Exp. (TTM) (Millions $) 0

Business Description


Paxmedica Inc is a medical technology company that specializes in the development and manufacturing of innovative healthcare products. The company focuses on creating advanced solutions that enhance patient care and improve clinical outcomes. Paxmedica Inc's products are designed to meet the needs of healthcare professionals and patients, with a particular emphasis on safety, efficacy, and user-friendliness. The company aims to contribute to the evolution of the healthcare industry by integrating cutting-edge technology and research into their product development process.


   Company Address: 1000 Wycoff Ave Mahwah 7430 NJ
   Company Phone Number: 977-9461   Stock Exchange / Ticker: PXMD


   

Stock Performances by Major Competitors

5 Days Decrease / Increase
     
ACAD   -2.5%    
ALKS   -3.85%    
BMRN        0.25% 
REGN   -3.55%    
SUPN   -2%    
VRTX   -0.56%    
• View Complete Report
   



Announcement

PaxMedica Appeals Nasdaq Delisting and Prepares for FDA Meeting on PAX-101

Published Wed, May 15 2024 12:30 PM UTC

New York-based biopharmaceutical company, PaxMedica, Inc. (OTC:PXMD), is currently facing a delisting threat by Nasdaq. In response, PaxMedica has taken swift action by filing an appeal with the Nasdaq Office of Appeals and Review. The company also announced its preparations for an upcoming meeting with the U.S. Food and Drug Administration (FDA) regarding its innovative dru...
Management Announcement

PaxMedica Steps Up to Combat Sleeping Sickness Crisis in Malawi with Emergency Supply of IV Suramin

Published Tue, Apr 23 2024 12:30 PM UTC

PaxMedica Responds to Emergency Request for IV Suramin and Commits to Provide Immediate Access to PAX-101
PaxMedica Inc. (Nasdaq: PXMD), a leading biopharmaceutical company dedicated to advancing treatments for neurological disorders, has announced its swift response to an urgent request from the Ministry of Health (MOH) of Malawi in east Africa. The MOH seeks emergency...
Management Announcement

PaxMedica Revolutionizes Autism Spectrum Disorder Treatments with Groundbreaking Innovations

Published Wed, Mar 13 2024 12:20 PM UTC

PaxMedica Unveils Innovations in Autism Spectrum Disorder Treatments in Latest Company Presentation
TARRYTOWN, New York, March 13, 2024 - PaxMedica, Inc. (NASDAQ: PXMD), a leading biopharmaceutical company specializing in neurological disorder treatments, announced today the release of its latest company presentation. This comprehensive overview highlights PaxMedica s st...



Fundamental Analysis

Valuation Current
Price to Earnings PE Ratio (TTM) -
Price to Earnings PE Ratio (Expected) -
Price to Sales (TTM) -
Price to Sales (Expected) -
Price to Book -
PEG (TTM) -

Financial Strength Current
Quick Ratio 0.2
Working Capital Ratio 0.36
Leverage Ratio (MRQ) -
Total Debt to Equity -
Interest Coverage (TTM) -
Debt Coverage (TTM) -

Per Share Current
Earnings (TTM) -4.55 $
Revenues (TTM) -
Cash Flow (TTM) -
Cash 0.05 $
Book Value -
Dividend (TTM) 0 $

Efficiency Current
Revenue per Employee (TTM) -
Net Income per Employee (TTM) -1,354,110
Receivable Turnover Ratio (TTM) -
Inventory Turnover Ratio (TTM) -
Asset Turnover Ratio (TTM) -

Profitability Ratios Current
Gross Margin (MRQ) -
Operating Margin (MRQ) -
Net Margin (MRQ) -
Net Cash Flow Margin (MRQ) -
Effective Tax Rate (TTM) -

Management Effectiveness Current
Return On Assets (TTM) -
Return On Investment (TTM) -
Return On Equity (TTM) -
Dividend Yield -
Pay out Ratio (TTM) -






Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.